Lam_2020_Biomed.Pharmacother_130_110624

Reference

Title : Melaleuca alternifolia (tea tree) oil and its monoterpene constituents in treating protozoan and helminthic infections - Lam_2020_Biomed.Pharmacother_130_110624
Author(s) : Lam NS , Long X , Su XZ , Lu F
Ref : Biomed Pharmacother , 130 :110624 , 2020
Abstract :

Australian tea tree (Melaleuca alternifolia) oil (TTO) and its monoterpene constituents such as terpinen-4-ol (T4O), 1,8-cineole, limonene, p-cymene, and alpha-terpinene have been shown to be effective in controlling a wide range of parasitic infections. The anti-parasitic effects of these compounds are mainly due to their anti-histamine and anti-acetylcholinesterase activities as well as their ability to modulate host inflammatory responses. This review attempts to summarize recent advances in the uses of TTO and its 15 major monoterpene constituents in treating parasitic infections in both humans and animals. Activities against parasitic protozoans (Plasmodium falciparum, Leishmania spp., Trypanosoma spp., Acanthamoeba castellanii, Trichomonas vaginalis, Eimeria, and Ichthyophthirius multifiliis), nematodes (Haemonchus contortus and Anisakis simplex), cestode (Echinococcus ortleppi), and monogeneans (Gasterosteus spp. and Dactylogyrus minutus) have been reported, showing good potentials in treating parasitic infections. Further studies are necessary for developing anti-parasite therapies using TTO or its monoterpenes constituents.

PubMedSearch : Lam_2020_Biomed.Pharmacother_130_110624
PubMedID: 33503761

Related information

Citations formats

Lam NS, Long X, Su XZ, Lu F (2020)
Melaleuca alternifolia (tea tree) oil and its monoterpene constituents in treating protozoan and helminthic infections
Biomed Pharmacother 130 :110624

Lam NS, Long X, Su XZ, Lu F (2020)
Biomed Pharmacother 130 :110624